ROLE OF HUMAN PAPILLOMAVIRUS IN CERVICAL NEOPLASIA
ROLE OF HUMAN PAPILLOMAVIRUS IN CERVICAL NEOPLASIA
批准号:
3422949
负责人:
Barbara S Hulka
金额:
$0.68万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-07-01 至 1989-06-30
关键词:
Papillomavirus cancer risk cervical /vaginal smear cervix neoplasms cocarcinogen female female antifertility drug genital herpes human subject neoplasm /cancer classification /staging neoplasm /cancer epidemiology sexually transmitted diseases tobacco abuse virus DNA virus classification virus related neoplasm /cancer
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The purpose of this case control study is to investigate the role
Human Papillomavirus (HPV) DNA types 6, 11, 16, 18, and 31 play
in the development of cervical intraepithelial neoplasia (CIN)
levels II and III, controlling for known and suspected risk factors,
HPV DNA types 16, 18, and 31 have been found to be associated
with CIN II and III, while HPV DNA types 6 and 11 are found more
frequently in CIN I. This research project hypothesizes that
women with CIN II and III are more likely to have HPV DNA types
16, 18, and 31 compared to women with normal cervical smears.
Since HPV usually requires an associated carcinogenic agent for
malignant transformation in animal tumor models, the role of past
genital herpes infection, smoking, and hormonal contraceptives
will be evaluated as possible co-carcinogens.
The North Carolina Memorial Hospital (NCMH) Neoplasia Clinic
will serve as the source of 100 incident cases of CIN II and III as
classified by the NCMH cytology laboratory. Biopsy confirmation
of CIN II or III will also be a requirement for case status. 200
NCMH Family Medicine Clinic patients receiving routine Pap
smears, classified as normal by the NCMH cytology laboratory,
will serve as the controls. An additional cervical scraping will be
taken from each case and control for HPV DNA typing. All cases
and controls will be interviewed by telephone to collect
information on potential confounders including: age, race,
education, age at first intercourse, number of sexual partners,
tobacco use, history of sexually transmitted diseases, and
contraceptive methods used.
Stratified analysis and unconditional logistic regression will be
used to investigate the relationship between HPV DNA types and
cervical neoplasia status, while controlling for risk factors. The
possibility of interactions between HPV DNA types and the
hypothesized co-carcinogenic agents (past genital herpes
infection, smoking status, and hormonal contraceptives used) will
be evaluated using unconditional logistic regression.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Oral contraceptive use and cervical intraepithelial neoplasia.
口服避孕药的使用和宫颈上皮内瘤变。
DOI:
10.1016/0895-4356(92)90151-c
发表时间:
1992
期刊:
Journal of clinical epidemiology
影响因子:
7.2
作者:
[Coker,AL, McCann,MF, Hulka,BS, Walton,LA]
通讯作者:
Walton,LA
Active and passive cigarette smoke exposure and cervical intraepithelial neoplasia.
主动和被动香烟烟雾暴露与宫颈上皮内瘤变。
DOI:
--
发表时间:
1992
期刊:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子:
--
作者:
[Coker,AL, Rosenberg,AJ, McCann,MF, Hulka,BS]
通讯作者:
Hulka,BS
DOI:
10.1016/0010-7824(92)90136-h
发表时间:
1992
期刊:
Contraception
影响因子:
2.9
作者:
[Coker,AL, Hulka,BS, McCann,MF, Walton,LA]
通讯作者:
Walton,LA
CORE--CANCER EPIDEMIOLOGY
-
批准号:6563735
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2002
-
负责人:Barbara S Hulka
-
依托单位:
CORE--CANCER EPIDEMIOLOGY
-
批准号:6448163
-
项目类别:
-
资助金额:$15.83万
-
财政年份:2001
-
负责人:Barbara S Hulka
-
依托单位:
WOMEN'S HEALTH INITIATIVE
-
批准号:6566155
-
项目类别:
-
资助金额:$19.07万
-
财政年份:2001
-
负责人:Barbara S Hulka
-
依托单位:
CORE--CANCER EPIDEMIOLOGY
-
批准号:6448913
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2001
-
负责人:Barbara S Hulka
-
依托单位:
WOMEN'S HEALTH INITIATIVE
-
批准号:6423326
-
项目类别:
-
资助金额:$29.46万
-
财政年份:2000
-
负责人:Barbara S Hulka
-
依托单位:
WOMEN'S HEALTH INITIATIVE
-
批准号:6504303
-
项目类别:
-
资助金额:$19.07万
-
财政年份:2000
-
负责人:Barbara S Hulka
-
依托单位:
CORE--CANCER EPIDEMIOLOGY
-
批准号:6395627
-
项目类别:
-
资助金额:$8.95万
-
财政年份:1999
-
负责人:Barbara S Hulka
-
依托单位:
CORE--CANCER EPIDEMIOLOGY
-
批准号:6398236
-
项目类别:
-
资助金额:$8.95万
-
财政年份:1999
-
负责人:Barbara S Hulka
-
依托单位:
PROGRESSION FROM BENIGN BREAST DISEASE TO BREAST CANCER--IMMUNOHISTOCHEMISTRY
-
批准号:6356225
-
项目类别:
-
资助金额:$16.85万
-
财政年份:1999
-
负责人:Barbara S Hulka
-
依托单位:
PROGRESSION FROM BENIGN BREAST DISEASE TO BREAST CANCER--IMMUNOHISTOCHEMISTRY
-
批准号:6203250
-
项目类别:
-
资助金额:$16.85万
-
财政年份:1999
-
负责人:Barbara S Hulka
-
依托单位:
CORE--CANCER EPIDEMIOLOGY
-
批准号:6396752
-
项目类别:
-
资助金额:$8.95万
-
财政年份:1999
-
负责人:Barbara S Hulka
-
依托单位:
PROGRESSION FROM BENIGN BREAST DISEASE TO BREAST CANCER--IMMUNOHISTOCHEMISTRY
-
批准号:6483387
-
项目类别:
-
资助金额:$16.85万
-
财政年份:1999
-
负责人:Barbara S Hulka
-
依托单位:
HRT AND CHANGES IN MAMMOGRAPHIC DENSITY
-
批准号:6137624
-
项目类别:
-
资助金额:$29.14万
-
财政年份:1998
-
负责人:Barbara S Hulka
-
依托单位:
HRT AND CHANGES IN MAMMOGRAPHIC DENSITY
-
批准号:2443356
-
项目类别:
-
资助金额:$29.33万
-
财政年份:1998
-
负责人:Barbara S Hulka
-
依托单位:
HRT AND CHANGES IN MAMMOGRAPHIC DENSITY
-
批准号:2856470
-
项目类别:
-
资助金额:$30.07万
-
财政年份:1998
-
负责人:Barbara S Hulka
-
依托单位:
CORE--CANCER EPIDEMIOLOGY
-
批准号:6395646
-
项目类别:
-
资助金额:$15.45万
-
财政年份:1998
-
负责人:Barbara S Hulka
-
依托单位:
CORE--CANCER EPIDEMIOLOGY
-
批准号:6101755
-
项目类别:
-
资助金额:$8.95万
-
财政年份:1998
-
负责人:Barbara S Hulka
-
依托单位:
PROGRESSION FROM BENIGN BREAST DISEASE TO BREAST CANCER--IMMUNOHISTOCHEMISTRY
-
批准号:6102857
-
项目类别:
-
资助金额:$16.85万
-
财政年份:1998
-
负责人:Barbara S Hulka
-
依托单位:
CORE--CANCER EPIDEMIOLOGY
-
批准号:6268888
-
项目类别:
-
资助金额:$15.45万
-
财政年份:1998
-
负责人:Barbara S Hulka
-
依托单位:
WOMEN'S HEALTH INITIATIVE
-
批准号:6217960
-
项目类别:
-
资助金额:$0.02万
-
财政年份:1998
-
负责人:Barbara S Hulka
-
依托单位:
海外基金